Atlas Trials

Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients

Clinical trial NCT03135548 · COMPLETED

Trial details

NCT number
NCT03135548
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Psoriasis
Start date
2017-05-30
Primary completion
2018-07-12
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.